Skip to main content

Table 1 Demographic and clinical data for the in vivo therapeutic efficacy study (A) and the in vitro drug assay (B)

From: Chloroquine efficacy studies confirm drug susceptibility of Plasmodium vivax in Chennai, India

A. In vivo therapeutic efficacy study

B. In vitro drug assay

Characteristics

(N = 125)

Characteristics

 

(N = 96)

Sex [n (%)]

Male

120 (95.0)

Sex [n (%)]

Male

85 (88.5)

 

Female

5 (5.0)

 

Female

11 (11.5)

Wt (kg)

  

Age (yr)

  
 

Mean

52.8

 

Mean

23.9

 

Range

5.0-77.0

 

Range

7-53

 

SD

±10.4

 

SD

8.3

 

95% CI

51.0-54.7

 

95% CI

22.2-25.6

Age (yr)

Parasite count (n/μl)

 
 

Mean

25.9

 

Mean

6348.6

 

Range

13-66

 

Range

480-21,522

 

SD

10.5

 

SD

4390.8

 

95% CI

24.0-27.8

 

95% CI

5,172.8-7,524.5

Body temperature (°F)

 

Parasitaemia (%)

 
 

Mean

98.5

 

Mean

0.163

 

Range

95.4-104.4

 

Range

0.032-0.445

 

SD

2.2

 

SD

0.094

 

95% CI

98.1-98.9

 

95% CI

0.122-0.203

Haemoglobin (g/dl)

 

Rings (%)

 
 

Mean

14.4

 

Mean

3.2

 

Range

12.0-16.6

 

Range

0.0-33.3

 

SD

1.0

 

SD

5.9

 

95% CI

14.2-14.6

 

95% CI

1.9-4.6

Parasite count (n/μl)

 

Trophozoites (%)

 
 

Mean

9049.2

 

Mean

91.0

 

Range

1,000-57,200

 

Range

58.3-100.0

 

SD

6697.3

 

SD

11.6

 

95% CI

5,243.4-7,624.4

 

95% CI

88.4-93.6

   

Schizonts (%)

  
    

Mean

5.8

    

Range

0.0-33.3

    

SD

1.1

    

95% CI

3.6-7.9